Patients Breathing through barriers: Lived experience, innovation, an... When a disease runs in your family, you don’t learn about it from textbooks. You learn about it at funerals, in hospital beds, and emergency rooms.
Digital The role of NHS Big Data and AI technology in unlocking the ... The UK stands at the cusp of a new era of medical breakthroughs, fuelled by the increased use of data and the recent plans to open NHS data reserves to improve the development and creation
Views & Analysis Nontuberculous mycobacteria – an emerging public health prob... The challenge of treating Nontuberculous mycobacteria.
Views & Analysis Collaboration the key to success in respiratory research Lung research needs support as fifth of UK diagnosed with respiratory condition.
News Biomarker trial to show drug value in rare lung disease Growing incidence of IPF raises need for better means of determining diagnosis and treatment success.
News Appeal finds NICE must reconsider Alzheimer's drugs Lilly and Eisai's bid to secure NHS coverage of their Alzheimer's therapies has entered a new phase, after an appeal of last year's rejection by NICE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.